Skip to content
Screener

Generate Biomedicines, Inc. GENB Market capitalization

Market capitalization at other companies

Southern Company logo
Southern CompanySO
$108.04B+7.1%
AutoZone logo
AutoZoneAZO
$48.05B-22.3%
Synopsys logo
SynopsysSNPS
$92.45B+36.2%
Northern Trust logo
Northern TrustNTRS
$25.87B+34.5%
Dycom Industries logo
Dycom IndustriesDY
$12.43B+163%
Nucor logo
NucorNUE
$38.51B+38.8%

Other financials

Income statement

See full
Revenue$6.3M-37.7%
Operating income-$71.6M-19.1%
Net income-$67.3M-28.3%
EPS (diluted)-$0.52+73.2%

Balance sheet

See full
Cash & equivalents$135.4M-12.3%
Total debt$62.6M—
Total equity$456.0M+188%
Total assets$561.7M—

Cash flow

See full
Operating cash flow-$57.9M-18.9%
CapEx$933.0K+506%
Free cash flow-$58.9M-20.4%

Valuation

See full
Enterprise value$1.78B—
P/S57.2×—

Profitability

See full
Operating margin-751.2%—
Net margin-685.9%—
FCF margin-756.9%—

Returns & leverage

See full
Return on equity2,979.4%—
Debt / equity0.1×—
Current ratio8.3×—

Where this comes from

Computed from the period-end share price: $2.16B.

The source filing: Generate Biomedicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 6:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336437

FAQ

What is Generate Biomedicines, Inc.'s market capitalization?
Generate Biomedicines, Inc. (GENB) reported market capitalization of $2.16B in Q2 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Generate Biomedicines, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude